Frank Verwiel

Insider Reports History

Entity
Individual
Location
C/O Intermune, Inc., 3280 Bayshore Blvd., Brisbane, CA
Signature
/s/ James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Verwiel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. Director Common Stock 17.9K $449K $25.00 Jun 17, 2024 Direct
Intellia Therapeutics, Inc. Director Stock Option (right to buy) 11.5K Jun 12, 2024 Direct

Insider Reports Filed by Frank Verwiel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTLA Intellia Therapeutics, Inc. Jun 17, 2024 1 -$37.6K 4 Jun 20, 2024 Director
NTLA Intellia Therapeutics, Inc. Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
NTLA Intellia Therapeutics, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
NTLA Intellia Therapeutics, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
NTLA Intellia Therapeutics, Inc. Jun 23, 2021 2 $0 4 Jun 25, 2021 Director